Showing results (71-80 of 182) with videos related to

Sort By:
Pageof 19
The Lancet. Oncology|September 5, 2020
Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapyLisa Bodei, Heiko Schöder, Richard P Baum, et al.
Journal of Applied Clinical Medical Physics|August 22, 2008
Time-course of effects of external beam radiation on [18F]FDG uptake in healthy tissue and bone marrowAdam L Kesner, Victoria K Lau, Michael Speiser, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Differential Clearance of [<sup>177</sup>Lu]Lu-PSMA-617 from Metastatic Prostate Cancer Lesions and Normal Tissues creates a Window for Safe Application of DNA Repair InhibitorsJames Russell, Milan Grkovski, Joseph A O'Donoghue, et al.
Neuroendocrinology|September 27, 2019
Neuroendocrine Neoplasms of the Small Bowel and PancreasAshley Kieran Clift, Mark Kidd, Lisa Bodei, et al.
Medicine|February 3, 2018
Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case reportGiuseppe Corrias, Natally Horvat, Serena Monti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 27, 2007
EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin)Jan Tennvall, Manfred Fischer, Angelika Bischof Delaloye, et al.
Annals of Surgical Oncology|November 28, 2019
Utility of Quantitative SPECT/CT Lymphoscintigraphy in Guiding Sentinel Lymph Node Biopsy in Head and Neck MelanomaJennifer J Kwak, Adam L Kesner, Ana Gleisner, et al.
Molecular Imaging and Biology|February 14, 2009
Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's diseaseClaudia Kuntner, Adam L Kesner, Martin Bauer, et al.
Gynecologic Oncology|June 16, 2004
Radioimmunotherapy in advanced ovarian cancer: is there a role for pre-targeting with (90)Y-biotin?Chiara Grana, Mirco Bartolomei, Daria Handkiewicz, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 1, 2008
Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposalMaria Vittoria Davì, Lisa Bodei, Marco Ferdeghini, et al.
Pageof 19